Medicine · Rheumatology (SLE, RA, Vasculitis, Crystal Arthropathies, Scleroderma)

A 45-year-old woman with rheumatoid arthritis is scheduled to start infliximab. Which of the following is mandatory before initiating anti-TNF therapy?

  • A Hepatitis B surface antigen testing
  • B Screening for latent tuberculosis
  • C Chest X-ray
  • D Quantiferon-TB Gold test alone without PPD
Correct answer: B. Screening for latent tuberculosis

Explanation

Anti-TNF agents significantly increase the risk of reactivating latent tuberculosis. Therefore, screening for latent TB (by PPD or interferon-gamma release assay) is mandatory before starting therapy. Hepatitis B screening is important but TB reactivation is the most critical concern. Chest X-ray is part of evaluation but not sufficient alone.

Reference: Harrison's Principles of Internal Medicine, 21st ed.

High-yield for: NEET PGINI-CETNExTFMGEUSMLEPLABMRCP

Written and medically reviewed by the StethoPrep medical team.

Sponsored

Want to test yourself?

Create a free account for timed mock tests, mistake tracking, and FSRS spaced-repetition revision across 43,000+ MCQs.

Start free → Log in

More Rheumatology (SLE, RA, Vasculitis, Crystal Arthropathies, Scleroderma) MCQs

See all Rheumatology (SLE, RA, Vasculitis, Crystal Arthropathies, Scleroderma) MCQs →